Impact of RSV Immunization on the Rate of Pediatric Acute Otitis Media: A Time-series Analysis
- 9 October 2025
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
Abstract
Background: Acute otitis media (AOM) is the leading cause of antibiotic prescription in children. Respiratory syncytial virus (RSV) is suspected to play an important role in AOM. The aim of this study was to estimate the impact of RSV immunization on the rate of subsequent AOM in children, as this effect remains unknown. Methods: We conducted an interrupted time-series analysis based on a French network involving 110 ambulatory pediatricians, trained in pediatric infectious diseases (PARI network). All ambulatory visits for AOM, from June 2017 to February 2025 were included. The main outcome was the monthly rate of pediatric ambulatory visits for AOM in infants aged < 12 months per 1000 pediatric ambulatory visits over time, assessed by a seasonally adjusted quasi-Poisson regression model. Bronchiolitis and urinary tract infections (UTI) were analyzed over the same period, as positive and negative controls, respectively. Results: We included 70 452 cases of AOM, 13 284 bronchiolitis and 814 UTI. The rate of AOM per 1000 visits in infants aged < 12 months significantly decreased after RSV immunization implementation (−23.7%, 95% CI −37.6 to −9.7, P = .0014), whereas no significant change was observed in older age groups. We observed similar trends for bronchiolitis. The monthly rate of UTI did not significantly decrease. Conclusions: RSV immunization led to a strong reduction of AOM rate in infants aged < 12 months. Beyond its efficacy in preventing RSV-related lower respiratory infections in infants aged < 12 months, RSV immunization may contribute to reduce the burden of AOM in children.Keywords
Funding Information
- National Institute for Health and Medical Research
- French National Center for Scientific Research
- La Fondation de l’Assistance Publique-Hôpitaux de Paris (LCOV23)
This publication has 19 references indexed in Scilit:
- Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021The Lancet Infectious Diseases, 2024
- Effectiveness of nirsevimab against RSV-bronchiolitis in paediatric ambulatory care: a test-negative case–control studyThe Lancet Regional Health - Europe, 2024
- Interactions between respiratory syncytial virus and Streptococcus pneumoniae in the pathogenesis of childhood respiratory infections: a systematic reviewThe Lancet Respiratory Medicine, 2024
- Nirsevimab for Prevention of Hospitalizations Due to RSV in InfantsNew England Journal of Medicine, 2023
- Effectiveness of Pneumococcal Vaccines on Otitis Media in Children: A Systematic ReviewValue in Health, 2022
- Pediatric Ambulatory and Hospital Networks for Surveillance and Clinical Epidemiology of Community-Acquired InfectionsThe Journal of Pediatrics, 2018
- Prevention of early episodes of otitis media by pneumococcal vaccines might reduce progression to complex diseaseThe Lancet Infectious Diseases, 2016
- Interrupted time series analysis in drug utilization research is increasing: systematic review and recommendationsJournal of Clinical Epidemiology, 2015
- Acute otitis media in infants younger than three months not vaccinated against Streptococcus pneumoniaeInternational Journal of Pediatric Otorhinolaryngology, 2013
- Segmented regression analysis of interrupted time series studies in medication use researchJournal of Clinical Pharmacy and Therapeutics, 2002